Wednesday, July 8, 2026

biotech · Fontan Procedure · CSBR

CHAMPIONS ONCOLOGY

CHAMPIONS ONCOLOGY patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Hackensack, USA HQ
2007 Founded
183 Employees
Public company Type
CSBR · NYSE Ticker
Company details
Status
Public
HQ
Hackensack, USA
Founded
2007
Employees
183
Programs
1
Drugs
2
Patents
1
Intelligence · Patents

CHAMPIONS ONCOLOGY patents

1 pharmaceutical patents indexed for CHAMPIONS ONCOLOGY. 0 expire within 24 months.

CHAMPIONS ONCOLOGY has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 7595326

    Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs

    Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does CHAMPIONS ONCOLOGY have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do CHAMPIONS ONCOLOGY patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.